RxDoctor Payments Data

Aaron Tabor, MD

Psychiatry · Ardmore, OKNPI 1194080424

Payments from drug & device makers

$2,229in general payments, 2019–2025

Across 118 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$350
  • Johnson & Johnson$342
  • Corium, LLC$315
  • Otsuka America Pharmaceutical, Inc.$248
  • Supernus Pharmaceuticals, Inc.$186
  • Teva Pharmaceuticals USA, Inc.$185
  • plus $603 from 9 others

What the payments were for

  • Food & beverage$2,12595%
  • Education$1045%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,229 in reported general payments places this provider in the 80th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$42,486
Medicare patients
93
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine21$282,873
VraylarCariprazine Hcl90$170,126
SpravatoEsketamine Hcl28$163,242
IngrezzaValbenazine Tosylate11$94,391
CaplytaLumateperone Tosylate42$73,991
NuplazidPimavanserin Tartrate15$62,176
Invega SustennaPaliperidone Palmitate17$52,567
Abilify MaintenaAripiprazole13$36,137
AuvelityDextromethorphan Hbr/Bupropion31$34,188
TrintellixVortioxetine Hydrobromide31$14,583
Lamotrigine162$8,250
BelsomraSuvorexant15$7,555
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine161$7,205
Venlafaxine Hcl ErVenlafaxine Hcl63$5,361
VyvanseLisdexamfetamine Dimesylate12$4,827

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$185$282,87321 claims
Johnson & JohnsonSpravato, Invega Sustenna$342$215,80845 claims
AbbVieVraylar$350$170,12690 claims
Neurocrine Biosciences, Inc.Ingrezza$43$94,39111 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$108$73,99142 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$248$36,13713 claims
Axsome Therapeutics, Inc.Auvelity$59$34,18831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 328 psychiatry providers in Oklahoma.

Other psychiatry in Ardmore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →